Similar articles

• Science, ethics and economics in FDA decision-making: the legal framework.

  Cooper RM. Cooper RM. Food Drug Law J. 2006;61(4):799-803. Food Drug Law J. 2006. PMID: 17180773 No abstract available.
• HHS ruling on Plan B introduces new risk for drugmakers.

  Willyard C. Willyard C. Nat Med. 2012 Jan 6;18(1):8. doi: 10.1038/nm0112-8a. Nat Med. 2012. PMID: 22227652 No abstract available.
• Politics trumps science at the FDA.

  [No authors listed] [No authors listed] Lancet. 2005 Nov 26;366(9500):1827. doi: 10.1016/S0140-6736(05)67733-1. Lancet. 2005. PMID: 16310533 No abstract available.
• FDA Drug Approval and the Ethics of Desperation.

  Largent EA, Peterson A, Lynch HF. Largent EA, et al. JAMA Intern Med. 2021 Dec 1;181(12):1555-1556. doi: 10.1001/jamainternmed.2021.6045. JAMA Intern Med. 2021. PMID: 34694325 Free PMC article. Review. No abstract available.
• Drug regulation, product liability, and the contraceptive crunch. Choices are dwindling.

  Isaacs SL, Holt R. Isaacs SL, et al. J Leg Med. 1987 Dec;8(4):533-53. doi: 10.1080/01947648709513514. J Leg Med. 1987. PMID: 3323385 Review. No abstract available.